Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AstaReal (formerly Fuji Health Science) is a global leader in the production and innovation of natural astaxanthin, a powerful antioxidant derived from the microalgae Haematococcus pluvialis. As a subsidiary of Fuji Chemical Industries, the company pioneered the commercial production of natural astaxanthin and provides high-quality ingredients for the nutraceutical, functional food, and cosmetic industries. Their business focuses on clinical research and the development of specialized delivery forms, such as water-soluble powders and oil extracts, to support human health in areas including muscle endurance, skin health, and cognitive function. The company is recognized for its rigorous cultivation standards and extensive portfolio of clinical studies validating the efficacy of its flagship brand, AstaReal.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fuji Health Science.